Enliven Therapeutics to Present at the Jefferies London Healthcare Conference
Enliven Therapeutics, a clinical-stage biopharmaceutical company, announced its participation in the Jefferies London Healthcare Conference on November 19, 2024, at 9:30 a.m. GMT. The company's management will engage in a fireside chat, which will be webcast live. Interested parties can access the webcast via the investor relations section of Enliven's website. The webcast will remain available for 90 days post-event.
Enliven Therapeutics, una società biofarmaceutica in fase clinica, ha annunciato la sua partecipazione alla Jefferies London Healthcare Conference il 19 novembre 2024, alle 9:30 ora GMT. La direzione dell'azienda parteciperà a un fireside chat, che sarà trasmesso in diretta. Le parti interessate possono accedere al webcast tramite la sezione delle relazioni con gli investitori del sito web di Enliven. Il webcast rimarrà disponibile per 90 giorni dopo l'evento.
Enliven Therapeutics, una compañía biofarmacéutica en etapa clínica, anunció su participación en la Jefferies London Healthcare Conference el 19 de noviembre de 2024, a las 9:30 a.m. GMT. La dirección de la compañía participará en una charla junto a la chimenea, que será transmitida en vivo. Las partes interesadas pueden acceder al webcast a través de la sección de relaciones con inversionistas del sitio web de Enliven. El webcast estará disponible durante 90 días después del evento.
엔라이븐 테라퓨틱스는 임상 단계의 생물제약 회사로, 2024년 11월 19일 오전 9시 30분 GMT에 제퍼리스 런던 헬스케어 컨퍼런스에 참가한다고 발표했습니다. 회사의 경영진은 파이어사이드 챗에 참여하며, 이는 실시간으로 전송될 것입니다. 관심 있는 분들은 엔라이븐의 웹사이트에 있는 투자자 관계 섹션을 통해 웹캐스트에 접근할 수 있습니다. 웹캐스트는 90일 동안 이벤트 이후에도 이용 가능합니다.
Enliven Therapeutics, une entreprise biopharmaceutique en phase clinique, a annoncé sa participation à la Conférence sur la santé de Jefferies à Londres le 19 novembre 2024 à 9h30 GMT. La direction de l'entreprise participera à une discussion au coin du feu, qui sera diffusée en direct. Les parties intéressées peuvent accéder au webcast via la section des relations investisseurs du site web d'Enliven. Le webcast restera disponible pendant 90 jours après l'événement.
Enliven Therapeutics, ein biopharmazeutisches Unternehmen in klinischer Phase, hat seine Teilnahme an der Jefferies London Healthcare Conference für den 19. November 2024 um 9:30 Uhr GMT bekannt gegeben. Die Unternehmensleitung wird an einem Feuerhausgespräch teilnehmen, das live übertragen wird. Interessierte können über den Bereich für Investorenbeziehungen auf der Website von Enliven auf das Webcast zugreifen. Das Webcast wird für 90 Tage nach der Veranstaltung verfügbar sein.
- None.
- None.
The fireside chat will be webcast live and can be accessed by visiting the investor relations section of the Company's website at https://ir.enliventherapeutics.com/. The webcast will be archived for a period of 90 days following the conclusion of the live event.
About Enliven
Enliven is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics to help people with cancer not only live longer, but live better. Enliven aims to address existing and emerging unmet needs with a precision oncology approach that improves survival and enhances overall well-being. Enliven's discovery process combines deep insights in clinically validated biological targets and differentiated chemistry to design potentially first-in-class or best-in-class therapies. Enliven is based in
View original content to download multimedia:https://www.prnewswire.com/news-releases/enliven-therapeutics-to-present-at-the-jefferies-london-healthcare-conference-302299207.html
SOURCE Enliven Therapeutics, Inc.
FAQ
When will Enliven Therapeutics participate in the Jefferies London Healthcare Conference?
How can I access the Enliven Therapeutics fireside chat webcast from the Jefferies London Healthcare Conference?
How long will the Enliven Therapeutics webcast be available after the Jefferies London Healthcare Conference?
What is the stock symbol for Enliven Therapeutics?
